Filter News
Area of Research
- (-) National Security (3)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (17)
- Building Technologies (3)
- Clean Energy (41)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Isotopes (5)
- Materials (11)
- Materials for Computing (2)
- Neutron Science (11)
- Supercomputing (21)
News Type
News Topics
- (-) Biomedical (4)
- (-) Buildings (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (12)
- Artificial Intelligence (12)
- Big Data (6)
- Bioenergy (4)
- Biology (5)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (21)
- Coronavirus (3)
- Cybersecurity (19)
- Decarbonization (3)
- Energy Storage (2)
- Environment (6)
- Exascale Computing (1)
- Frontier (1)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Isotopes (5)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (34)
- Neutron Science (9)
- Nuclear Energy (40)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (11)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
Every day, hundreds of thousands of commuters across the country travel from houses, apartments and other residential spaces to commercial buildings — from offices and schools to gyms and grocery stores.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.